Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 37 results for "roche"

Roche Diagnostics India looks at 15% IVD market share in 2 yrs
Business Standard

Roche Diagnostics India looks at 15% IVD market share in 2 yrs

Roche Diagnostics India is aiming at 15 per cent share of the in-vitro diagnostics market in the next two years as part of its growth plans in the country. Roche Diagnostics is part of Swiss healthcare major Roche. It sells devices and equipment to labs and ... Business Standard, 2 months ago

37 images for roche

Business Standard, 2 months ago
Breaking News, 3 months ago
Daiji World, 3 months ago
Mathrubhumi, 3 months ago
Breaking News, 3 months ago
Breaking News, 3 months ago
First Post.com, 3 months ago
DNA, 4 months ago
Daiji World, 4 months ago
Daiji World, 4 months ago

Halozyme to license drug delivery tech to Roche, Bristol-Myers

U.S. drugmaker Halozyme Therapeutics Inc said on Thursday it would license its drug delivery technology to Bristol-Myers Squibb Co and Swiss drugmaker Roche in separate collaborations. Shares of Halozyme rose 12.7 percent to $14.85 in premarket trading after ...
 Reuters2 months ago

'Double whammy' for Roche as manufacturing patent losses loom

By John Miller ZURICH (Reuters) - Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed.
 Sify1 month ago

Novartis' skin cancer drug posts win in trials, Roche flops

Novartis's mix of Tafinlar and Mekinist slashed the risk of melanoma returning or death by 53%
 Business Standard2 months ago Novartis posts a win, Roche a flop in skin cancer trials  Reuters2 months ago

FDA backs Roche's Gazyva in first-line follicular lymphoma

ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated follicular lymphoma, bolstering the Swiss drugmaker's efforts to strengthen its portfolio of blood cancer medicines.
 Reuters3 days ago Roche hemophilia drug wins FDA nod, with a warning  Reuters3 days ago FDA approves Roche hemophilia drug Hemlibra  Reuters3 days ago Roche MS drug Ocrevus wins European panel backing  Reuters1 week ago

GSK grabs Roche veteran and Calico scientist Barron as new R&D head

GlaxoSmithKline has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief Executive Emma Walmsley steps up her drive to improve productivity. Barron, who worked for Roche for many years before ...
 Reuters1 week ago

FDA approves Roche drugs for rare types of blood, lung cancers

(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer, and to market its drug Alecensa as a first choice of treatment for a subset of patients with ...
 Reuters1 week ago FDA approves Roche drug for rare type of blood cancer  Reuters1 week ago

UK's NICE gives Roche drug green light for bladder cancer

LONDON (Reuters) - Britain's healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche's immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer.
 Reuters2 weeks ago Roche's Alecensa wins EU panel's nod against mutated lung cancer  Reuters1 month ago Roche bladder cancer drug struggles as medics focus on survival  Reuters1 month ago Roche blood test could help 'personalize' cancer immunotherapy  Reuters2 months ago

Roche cancer immunotherapy Tecentriq wins EU approval

Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said. The European Commission approved Tecentriq, also known as atezolizumab, as a monotherapy for locally advanced or metastatic ...
 Reuters1 month ago Roche receives EU approval for Gazyvaro, European approval for Actemra  Reuters1 month ago

Roche shares hit by trial flops, fears over biosimilar defense

Roche shares fell in early trading on Monday after trial failures added to the Swiss drugmaker’s challenge of replacing patent-expired medicines with lucrative new drugs. Its skin cancer treatment Zelboraf flopped, the company said on Monday, while ...
 Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less